A gain-of-function mutation in the PCSK9 gene has been recognized in patients with familial hypercholesterolemia, which is correlated with the increased incidence and mortality rate of myocardial infarction (MI) [1,2,3]. The gene discussed is PCSK9; the disease is myocardial infarction.